Kits Eyecare(KTYCF)
$13.76+0.20 (+1.47%)
KTYCF
Kits Eyecare financials statements
$13.76
At close:+0.20 (+1.47%)
Kits Eyecare (KTYCF) Ratios
2 Followers
Kits Eyecare Ratios
KTYCF's free cash flow for Q2 2026 was C$6.38M. For the 2026 fiscal year, KTYCF's free cash flow was decreased by C$-1.38M and operating cash flow was C$7.76M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.34 | 1.16 | 1.39 | 1.51 | 2.12 |
| Quick Ratio | 0.82 | 0.58 | 0.76 | 0.84 | 1.32 |
| Cash Ratio | 0.66 | 0.50 | 0.65 | 0.77 | 1.22 |
| Solvency Ratio | 0.11 | 0.13 | 0.03 | -0.03 | -0.34 |
| Operating Cash Flow Ratio | 0.25 | 0.34 | 0.10 | 0.19 | -1.16 |
| Short-Term Operating Cash Flow Coverage | 1.12 | 2.42 | 0.79 | 1.51 | -6.38 |
| Net Current Asset Value | C$ 10.04M | C$ -59.00K | C$ -2.21M | C$ -3.16M | C$ -448.00K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.14 | 0.12 | 0.18 | 0.21 | 0.25 |
| Debt-to-Equity Ratio | 0.25 | 0.22 | 0.30 | 0.36 | 0.42 |
| Debt-to-Capital Ratio | 0.20 | 0.18 | 0.23 | 0.27 | 0.30 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.03 | 0.12 | 0.16 | 0.19 |
| Financial Leverage Ratio | 1.81 | 1.78 | 1.70 | 1.75 | 1.66 |
| Debt Service Coverage Ratio | 0.79 | 1.01 | 0.55 | 0.13 | -1.90 |
| Interest Coverage Ratio | 12.15 | 3.49 | -1.53 | -2.67 | -7.70 |
| Debt to Market Cap | 0.02 | 0.03 | 0.05 | 0.16 | 0.18 |
| Interest Debt Per Share | 0.51 | 0.45 | 0.54 | 0.67 | 0.81 |
| Net Debt to EBITDA | -1.31 | -0.80 | -0.35 | -0.90 | -0.17 |
| Profitability Margins | |||||
| Gross Profit Margin | 35.21% | 33.67% | 33.85% | 31.92% | 25.35% |
| EBIT Margin | 4.08% | 3.55% | -1.10% | -4.63% | -20.18% |
| EBITDA Margin | 5.26% | 5.22% | 1.54% | -0.79% | -17.29% |
| Operating Profit Margin | 4.08% | 3.41% | -1.98% | -4.75% | -20.68% |
| Pretax Profit Margin | 2.49% | 2.79% | -2.40% | -6.41% | -22.87% |
| Net Profit Margin | 1.54% | 1.96% | -1.84% | -4.97% | -17.74% |
| Continuous Operations Profit Margin | 1.54% | 1.96% | -1.84% | -4.97% | -17.74% |
| Net Income Per EBT | 61.62% | 70.01% | 76.62% | 77.47% | 77.57% |
| EBT Per EBIT | 61.06% | 82.03% | 121.37% | 135.02% | 110.55% |
| Return on Assets (ROA) | 2.75% | 3.02% | -2.53% | -4.85% | -16.07% |
| Return on Equity (ROE) | 4.99% | 5.38% | -4.31% | -8.48% | -26.68% |
| Return on Capital Employed (ROCE) | 12.23% | 8.44% | -3.77% | -6.27% | -23.00% |
| Return on Invested Capital (ROIC) | 6.47% | 5.39% | -2.73% | -4.61% | -17.01% |
| Return on Tangible Assets | 4.28% | 5.13% | -4.58% | -8.73% | -29.12% |
| Earnings Yield | 0.53% | 1.17% | -1.13% | -5.43% | -16.18% |
| Efficiency Ratios | |||||
| Receivables Turnover | 85.68 | 62.98 | 66.84 | 99.93 | 95.71 |
| Payables Turnover | 5.90 | 4.84 | 6.18 | 4.31 | 7.36 |
| Inventory Turnover | 5.54 | 4.70 | 5.17 | 3.80 | 4.56 |
| Fixed Asset Turnover | 22.20 | 14.67 | 13.93 | 9.13 | 7.54 |
| Asset Turnover | 1.79 | 1.55 | 1.38 | 0.98 | 0.91 |
| Working Capital Turnover Ratio | 18.72 | 20.20 | 10.95 | 5.83 | -30.67 |
| Cash Conversion Cycle | 8.31 | 8.06 | 16.99 | 15.05 | 34.21 |
| Days of Sales Outstanding | 4.26 | 5.80 | 5.46 | 3.65 | 3.81 |
| Days of Inventory Outstanding | 65.86 | 77.66 | 70.55 | 96.02 | 80.02 |
| Days of Payables Outstanding | 61.82 | 75.39 | 59.03 | 84.62 | 49.62 |
| Operating Cycle | 70.12 | 83.45 | 76.01 | 99.68 | 83.83 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.36 | 0.41 | 0.08 | 0.15 | -0.62 |
| Free Cash Flow Per Share | 0.35 | 0.31 | 0.06 | 0.14 | -0.74 |
| Dividend Paid and CapEx Coverage Ratio | 84.29 | 4.13 | 4.27 | 18.13 | -5.36 |
| Capital Expenditure Coverage Ratio | 84.29 | 4.13 | 4.27 | 18.13 | -5.36 |
| Operating Cash Flow Coverage Ratio | 0.72 | 1.03 | 0.16 | 0.24 | -0.85 |
| Operating Cash Flow to Sales Ratio | 0.06 | 0.08 | 0.02 | 0.05 | -0.24 |
| Free Cash Flow Yield | 1.93% | 3.72% | 0.94% | 5.27% | -25.56% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 188.97 | 85.32 | -88.44 | -18.41 | -6.18 |
| Price-to-Sales (P/S) Ratio | 2.90 | 1.67 | 1.63 | 0.91 | 1.10 |
| Price-to-Book (P/B) Ratio | 9.43 | 4.59 | 3.81 | 1.56 | 1.65 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 51.86 | 26.88 | 106.35 | 18.97 | -3.91 |
| Price-to-Operating Cash Flow Ratio | 51.25 | 20.38 | 81.45 | 17.92 | -4.64 |
| Price-to-Earnings Growth (PEG) Ratio | -103.72 | -0.36 | 1.67 | 0.27 | -0.06 |
| Enterprise Value Multiple | 53.88 | 31.16 | 105.09 | -117.15 | -6.51 |
| Enterprise Value | 573.52M | 259.00M | 195.25M | 84.46M | 92.79M |
| EV to EBITDA | 53.88 | 31.16 | 105.09 | -117.15 | -6.51 |
| EV to Sales | 2.83 | 1.63 | 1.62 | 0.92 | 1.13 |
| EV to Free Cash Flow | 50.63 | 26.21 | 106.00 | 19.11 | -4.02 |
| EV to Operating Cash Flow | 50.03 | 19.87 | 81.19 | 18.06 | -4.77 |
| Tangible Book Value Per Share | 0.68 | 0.49 | 0.39 | 0.38 | 0.45 |
| Shareholders’ Equity Per Share | 1.94 | 1.84 | 1.64 | 1.72 | 1.76 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.38 | 0.30 | 0.23 | 0.23 | 0.22 |
| Revenue Per Share | 6.32 | 5.06 | 3.84 | 2.93 | 2.64 |
| Net Income Per Share | 0.10 | 0.10 | -0.07 | -0.15 | -0.47 |
| Tax Burden | 0.62 | 0.70 | 0.77 | 0.77 | 0.78 |
| Interest Burden | 0.61 | 0.79 | 2.17 | 1.38 | 1.13 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
| SG&A to Revenue | 0.23 | 0.20 | 0.07 | 0.23 | 0.24 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.00 | 0.01 | 0.02 |
| Income Quality | 3.69 | 4.18 | -1.09 | -1.03 | 1.33 |
Currency in CAD
